MICHAEL W BONNEY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL W BONNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W BONNEY. MICHAEL W BONNEY is Director in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Director in NPS PHARMACEUTICALS INC ($NPSP) and Chief Executive Officer in CUBIST PHARMACEUTICALS INC ($CBST) and President & CEO in CUBIST PHARMACEUTICALS INC ($CBST) and President and CEO in CUBIST PHARMACEUTICALS INC ($CBST) and Director in Sarepta Therapeutics, Inc. ($SRPT) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Global Blood Therapeutics, Inc. ($GBT) and Director in Tekla World Healthcare Fund ($THW) and Director in Magenta Therapeutics, Inc. ($MGTA) and Director in Kaleido Biosciences, Inc. ($KLDO) and Executive Chair in Kaleido Biosciences, Inc. ($KLDO).
Latest Insider Trading Transactions of MICHAEL W BONNEY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BMY, CELG, CBST, GBT, KLDO, MGTA, NPSP, SRPT, SYRS, THW
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | M | 0.00 | 902 | 0 | 0 | |
| Jun 14 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Buy | M | 0.00 | 902 | 0 | 12,501 | 11.6 K to 12.5 K (+7.78 %) |
| Apr 02 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 366 | 0 | 8,930 | |
| Feb 03 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 3,054 | 0 | 8,565 | |
| Jan 05 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 372 | 0 | 5,468 | |
| Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
| Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
| Jul 02 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 392 | 0 | 4,639 | |
| Jul 01 2020 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Director | Option Exercise | A | 7.42 | 15,000 | 111,300 | 15,000 | |
| Jun 16 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | M | 0.00 | 558 | 0 | 0 | |
| Jun 16 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | M | 0.00 | 903 | 0 | 902 | |
| Jun 16 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Buy | M | 0.00 | 558 | 0 | 8,650 | 8.1 K to 8.7 K (+6.90 %) |
| Jun 16 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Buy | M | 0.00 | 903 | 0 | 8,092 | 7.2 K to 8.1 K (+12.56 %) |
| Jun 09 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Buy | P | 58.90 | 88 | 5,183 | 7,189 | 7.1 K to 7.2 K (+1.24 %) |
| Jun 09 2020 | MGTA | Magenta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 9.99 | 18,188 | 181,698 | 18,188 | |
| Jun 05 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | M | 0.00 | 2,949 | 0 | 5,898 | |
| Jun 05 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Buy | M | 0.00 | 2,949 | 0 | 7,189 | 4.2 K to 7.2 K (+69.55 %) |
| Apr 02 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 414 | 0 | 4,215 | |
| Apr 02 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 414 | 0 | 4,215 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 114.47 | 3,685 | 421,822 | 3,685 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 2,075 | 0 | 9,126 | 7.1 K to 9.1 K (+29.43 %) |
| Jan 03 2020 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 126 | 0 | 782 | |
| Nov 22 2019 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 656 | 0 | 656 | |
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 0.00 | 1,000 | 0 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 0.00 | 4,756 | 0 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 0.00 | 970 | 0 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 0.00 | 300 | 0 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 77.38 | 13,266 | 1,026,523 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 121.04 | 10,500 | 1,270,920 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 99.98 | 11,000 | 1,099,780 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 112.16 | 10,000 | 1,121,600 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | D | 115.78 | 10,000 | 1,157,800 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Sell | D | 0.00 | 2,000 | 0 | 0 | 2 K to 0 (-100.00 %) | |
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Sell | D | 0.00 | 2,209 | 0 | 0 | 2.2 K to 0 (-100.00 %) | |
| Sep 09 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Buy | P | 86.74 | 2,000 | 173,480 | 7,051 | 5.1 K to 7.1 K (+39.60 %) |
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | M | 0.00 | 375 | 0 | 0 | ||
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | M | 0.00 | 300 | 0 | 300 | ||
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | M | 0.00 | 484 | 0 | 970 | ||
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Buy | M | 0.00 | 375 | 0 | 2,209 | 1.8 K to 2.2 K (+20.45 %) | |
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Buy | M | 0.00 | 300 | 0 | 1,834 | 1.5 K to 1.8 K (+19.56 %) | |
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Buy | M | 0.00 | 484 | 0 | 1,534 | 1.1 K to 1.5 K (+46.10 %) | |
| Jun 11 2019 | MGTA | Magenta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 13.40 | 18,188 | 243,719 | 18,188 | |
| Jun 05 2019 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | A | 0.00 | 4,756 | 0 | 4,756 | ||
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Option Exercise | C | 0.00 | 450,000 | 0 | 0 | |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Option Exercise | C | 0.00 | 835,347 | 0 | 0 | |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Buy | C | 0.00 | 225,000 | 0 | 225,000 | 0 to 225 K |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Buy | C | 0.00 | 417,673 | 0 | 1,426,196 | 1 M to 1.4 M (+41.41 %) |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Buy | P | 14.65 | 2,555 | 37,431 | 1,008,523 | 1 M to 1 M (+0.25 %) |
| Mar 04 2019 | KLDO | Kaleido Bioscience ... | BONNEY MICHAEL W | Executive Chair | Buy | P | 13.95 | 68,965 | 962,062 | 1,005,968 | 937 K to 1 M (+7.36 %) |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 145.48 | 3,213 | 467,427 | 3,213 | |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 1,633 | 0 | 5,051 | 3.4 K to 5.1 K (+47.78 %) |
| Jun 27 2018 | MGTA | Magenta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | C | 0.00 | 6,429 | 0 | 0 | |
| Jun 27 2018 | MGTA | Magenta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | C | 0.00 | 50,025 | 0 | 0 | |
| Jun 27 2018 | MGTA | Magenta Therapeuti ... | BONNEY MICHAEL W | Director | Buy | C | 0.00 | 21,847 | 0 | 215,346 | 193.5 K to 215.3 K (+11.29 %) |
| Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
| Jun 15 2018 | SYRS | Syros Pharmaceutic ... | BONNEY MICHAEL W | Director | Option Exercise | A | 12.95 | 13,000 | 168,350 | 13,000 | |
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | M | 0.00 | 375 | 0 | 375 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | M | 0.00 | 300 | 0 | 600 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | A | 77.38 | 13,266 | 1,026,523 | 13,266 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Option Exercise | A | 0.00 | 1,454 | 0 | 1,454 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Buy | M | 0.00 | 375 | 0 | 1,050 | 675 to 1.1 K (+55.56 %) | |
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Buy | M | 0.00 | 300 | 0 | 675 | 375 to 675 (+80.00 %) | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 71.45 | 4,820 | 344,389 | 4,820 | |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Grant | A | 0.00 | 3,418 | 0 | 3,418 | 0 to 3.4 K |
| Dec 05 2017 | SRPT | Sarepta Therapeuti ... | BONNEY MICHAEL W | Director | Option Exercise | A | 54.29 | 16,400 | 890,356 | 16,400 | |
| Jun 16 2017 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Option Exercise | M | 0.00 | 375 | 0 | 750 | |
| Jun 16 2017 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 900 | 0 | 900 | |
| Jun 16 2017 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Option Exercise | A | 121.04 | 10,500 | 1,270,920 | 10,500 | |
| Jun 16 2017 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Buy | M | 0.00 | 375 | 0 | 375 | 0 to 375 |
| Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
| Jun 17 2016 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 1,125 | 0 | 1,125 | |
| Jun 17 2016 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Option Exercise | A | 99.98 | 11,000 | 1,099,780 | 11,000 | |
| Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
| Feb 10 2016 | GBT | Global Blood Thera ... | BONNEY MICHAEL W | Director | Option Exercise | A | 15.03 | 30,000 | 450,900 | 30,000 | |
| Mar 04 2016 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Buy | P | 103.01 | 2,000 | 206,028 | 2,000 | 0 to 2 K |
| Mar 10 2016 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Buy | P | 58.36 | 2,000 | 116,720 | 4,000 | 2 K to 4 K (+100.00 %) |
| Aug 18 2015 | THW | Tekla World Health ... | BONNEY MICHAEL W | Director | Buy | P | 18.35 | 10,917 | 200,294 | 10,917 | 0 to 10.9 K |
| Jun 19 2015 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
| Jun 19 2015 | CELG | CELGENE CORP /DE/ | BONNEY MICHAEL W | Director | Option Exercise | A | 112.16 | 10,000 | 1,121,600 | 10,000 | |
| Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 | |
| May 13 2015 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Buy | P | 112.16 | 2,000 | 224,320 | 2,000 | 0 to 2 K |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | BONNEY MICHAEL W | Director | Option Exercise | D | 0.00 | 167,608 | 0 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | BONNEY MICHAEL W | Director | Option Exercise | D | 0.00 | 3,816 | 0 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | BONNEY MICHAEL W | Director | Option Exercise | D | 4.24 | 36,000 | 152,640 | 0 | |
| Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | BONNEY MICHAEL W | Director | Sell | U | 46.00 | 13,900 | 639,400 | 0 | 13.9 K to 0 (-100.00 %) |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 0.00 | 37,389 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 73.55 | 140,550 | 10,337,453 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 0.00 | 60,096 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 41.60 | 184,044 | 7,656,230 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 0.00 | 19,000 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 42.09 | 200,000 | 8,418,000 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 34.80 | 175,000 | 6,089,125 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 0.00 | 8,000 | 0 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 21.56 | 135,000 | 2,910,600 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 16.76 | 150,000 | 2,514,000 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 18.10 | 150,000 | 2,715,000 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 19.51 | 125,000 | 2,438,750 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 21.61 | 80,000 | 1,728,800 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | D | 10.87 | 100,000 | 1,087,000 | 0 | |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | J | 102.00 | 600 | 61,200 | 0 | 600 to 0 (-100.00 %) |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | J | 102.00 | 6,816 | 695,232 | 0 | 6.8 K to 0 (-100.00 %) |
| Jan 21 2015 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | J | 102.00 | 176,226 | 17,975,052 | 0 | 176.2 K to 0 (-100.00 %) |
| Jul 02 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | J | 57.87 | 367 | 21,238 | 176,226 | 175.9 K to 176.2 K (+0.21 %) |
| May 15 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,250 | 0 | 0 | |
| May 15 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | S | 67.50 | 3,036 | 204,930 | 175,859 | 178.9 K to 175.9 K (-1.70 %) |
| May 15 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | M | 0.00 | 6,250 | 0 | 178,895 | 172.6 K to 178.9 K (+3.62 %) |
| May 14 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | M | 0.00 | 8,000 | 0 | 8,000 | |
| May 14 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | S | 69.00 | 3,840 | 264,960 | 172,645 | 176.5 K to 172.6 K (-2.18 %) |
| May 14 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | M | 0.00 | 8,000 | 0 | 176,485 | 168.5 K to 176.5 K (+4.75 %) |
| Apr 02 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | J | 73.15 | 213 | 15,581 | 6,816 | 6.6 K to 6.8 K (+3.23 %) |
| Feb 28 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | M | 10.84 | 100,000 | 1,084,000 | 0 | |
| Feb 28 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | S | 81.25 | 100,000 | 8,125,130 | 168,485 | 268.5 K to 168.5 K (-37.25 %) |
| Feb 28 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | M | 10.84 | 100,000 | 1,084,000 | 268,485 | 168.5 K to 268.5 K (+59.35 %) |
| Feb 21 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | M | 0.00 | 9,500 | 0 | 19,000 | |
| Feb 21 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | S | 75.60 | 3,112 | 235,268 | 168,485 | 171.6 K to 168.5 K (-1.81 %) |
| Feb 21 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | M | 0.00 | 9,500 | 0 | 171,597 | 162.1 K to 171.6 K (+5.86 %) |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | A | 0.00 | 37,389 | 0 | 37,389 | |
| Feb 19 2014 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | A | 73.55 | 140,550 | 10,337,453 | 140,550 | |
| Jul 02 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | J | 36.69 | 579 | 21,241 | 162,097 | 161.5 K to 162.1 K (+0.36 %) |
| May 22 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | M | 12.61 | 60,000 | 756,600 | 0 | |
| May 22 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | S | 50.00 | 60,000 | 3,000,006 | 161,518 | 221.5 K to 161.5 K (-27.09 %) |
| May 22 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | M | 12.61 | 60,000 | 756,600 | 221,518 | 161.5 K to 221.5 K (+37.15 %) |
| May 17 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| May 17 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | S | 47.88 | 2,400 | 114,902 | 161,518 | 163.9 K to 161.5 K (-1.46 %) |
| May 17 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | M | 0.00 | 5,000 | 0 | 163,918 | 158.9 K to 163.9 K (+3.15 %) |
| May 16 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,250 | 0 | 6,250 | |
| May 16 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | S | 48.41 | 2,979 | 144,227 | 158,918 | 161.9 K to 158.9 K (-1.84 %) |
| May 16 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | M | 0.00 | 6,250 | 0 | 161,897 | 155.6 K to 161.9 K (+4.02 %) |
| May 15 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Option Exercise | M | 0.00 | 8,000 | 0 | 16,000 | |
| May 15 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Sell | S | 49.18 | 3,753 | 184,569 | 155,647 | 159.4 K to 155.6 K (-2.35 %) |
| May 15 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | M | 0.00 | 8,000 | 0 | 159,400 | 151.4 K to 159.4 K (+5.28 %) |
| Apr 02 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | Chief Executive Off ... | Buy | J | 46.82 | 326 | 15,263 | 6,603 | 6.3 K to 6.6 K (+5.19 %) |
| Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Option Exercise | M | 0.00 | 9,500 | 0 | 28,500 | |
| Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Option Exercise | A | 41.60 | 184,044 | 7,656,230 | 184,044 | |
| Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Option Exercise | A | 0.00 | 60,096 | 0 | 60,096 | |
| Feb 20 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Buy | M | 0.00 | 9,500 | 0 | 152,000 | 142.5 K to 152 K (+6.67 %) |
| Jan 30 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Option Exercise | M | 8.23 | 65,100 | 535,773 | 0 | |
| Jan 30 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Option Exercise | M | 8.23 | 40,352 | 332,097 | 65,100 | |
| Jan 30 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Sell | S | 42.85 | 65,100 | 2,789,372 | 142,500 | 207.6 K to 142.5 K (-31.36 %) |
| Jan 30 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Buy | M | 8.23 | 65,100 | 535,773 | 207,600 | 142.5 K to 207.6 K (+45.68 %) |
| Jan 30 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Sell | S | 43.09 | 40,352 | 1,738,913 | 142,500 | 182.9 K to 142.5 K (-22.07 %) |
| Jan 30 2013 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Buy | M | 8.23 | 40,352 | 332,097 | 182,852 | 142.5 K to 182.9 K (+28.32 %) |
| Jul 03 2012 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President & CEO | Buy | J | 32.22 | 640 | 20,623 | 142,500 | 141.9 K to 142.5 K (+0.45 %) |
| May 16 2012 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President and CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
| May 16 2012 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 12,500 | |
| May 16 2012 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President and CEO | Sell | S | 41.85 | 2,098 | 87,801 | 147,877 | 150 K to 147.9 K (-1.40 %) |
| May 16 2012 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President and CEO | Sell | S | 41.90 | 2,147 | 89,962 | 149,975 | 152.1 K to 150 K (-1.41 %) |
| May 16 2012 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President and CEO | Buy | M | 0.00 | 5,000 | 0 | 152,122 | 147.1 K to 152.1 K (+3.40 %) |
| May 16 2012 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President and CEO | Buy | M | 0.00 | 6,250 | 0 | 147,122 | 140.9 K to 147.1 K (+4.44 %) |
| May 15 2012 | CBST | CUBIST PHARMACEUTI ... | BONNEY MICHAEL W | President and CEO | Option Exercise | M | 0.00 | 8,000 | 0 | 24,000 |